论文部分内容阅读
Purpose: Local progression, in patients with hormone-refractory prostate cancer, often causes significant morbidity.Pelvic radiotherapy (RT) provides effective palliation in this setting, with most published studies supporting the use of high-dose regimens.The aim of the present study was to examine the role of split-course hypofractionated RT used at our institution in treating this group of patients.